These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13826253)

  • 21. Anturan in the treatment of gout.
    LUCEY C
    Ir J Med Sci; 1961 Mar; 423():113-21. PubMed ID: 13763997
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of a new anti-inflammatory agent, G27202 on the gout crisis].
    MUGLER A
    Cah Rmf Bull Med Guide Pract Rev; 1962 Jun; 76():439-43. PubMed ID: 14476991
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinico-metabolic actoin of some phenylbutazone derivatives (G 27202, G 28315 and keto-phenylbutazone)].
    CIRLA E; RATTI G
    Reumatismo; 1960; 12():76-80. PubMed ID: 13693726
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
    YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB
    J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulphinpyrazone in the treatment of gout.
    FARN KT
    Practitioner; 1961 Aug; 187():212-4. PubMed ID: 13698233
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trials with a ne uricosuric agent, G 28,315 or anturan].
    de PREUX
    Schweiz Med Wochenschr; 1960 Jul; 90():760-2. PubMed ID: 14434812
    [No Abstract]   [Full Text] [Related]  

  • 27. [Observations made on the action of sulfinpyrazone in the treatment of gout after 3 years of recession].
    de PREUX
    Rev Rhum Mal Osteoartic; 1961 Apr; 28():181-3. PubMed ID: 13737911
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic gouty arthritis with Anturan (G-28315)].
    BORRACHERO J; DEL CARMEN SANCHEZ DE BORRACHERO M
    Medicina (Madr); 1962 Feb; 30():83-95. PubMed ID: 13871434
    [No Abstract]   [Full Text] [Related]  

  • 29. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiologic disposition and uricosuric effect of a keto analog of oxyphenbutazone (G-29701).
    SEEGMILLER JE; DAYTON PG; BURNS JJ
    Arthritis Rheum; 1960 Dec; 3():475-84. PubMed ID: 13749615
    [No Abstract]   [Full Text] [Related]  

  • 31. [Basic treatment of gout: current methods].
    Simon L; Claustre J; Serre H
    Cah Med; 1970 Jun; 11(7):651-67. PubMed ID: 4913606
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute gout--definitely a medical emergency.
    Bartels EC
    Med Clin North Am; 1969 Mar; 53(2):455-7. PubMed ID: 4305628
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenylbutazone (butazolidin) in gout.
    KUZELL WC; SCHAFFARZICK RW; NAUGLER WE; GAUDIN G; MANKLE EA; BROWN B
    Am J Med; 1954 Feb; 16(2):212-7. PubMed ID: 13124352
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of gout].
    Lejeune E; Durant J; Maitrepierre J
    J Med Lyon; 1970 Jan; 51(178):68-82. PubMed ID: 5527245
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of rheumatic arthritis and gout with phenylbutazone].
    PLICHET A
    Presse Med (1893); 1952 Sep; 60(58):1217-8. PubMed ID: 13026950
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practical problems in gout].
    Recordier AM
    Mars Med; 1965; 102(5):407-16. PubMed ID: 5889111
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gout (pathogenesis and therapy)].
    Chirone E
    Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of gout with butazolidin.
    HUNZIKER H
    Z Rheumaforsch; 1954 Oct; 13(9-10):296-307. PubMed ID: 13227345
    [No Abstract]   [Full Text] [Related]  

  • 39. [CASE OF CHRONIC TOPHOCEOUS GOUT].
    ITO H; OKAZAKI M; AKAOKA I; KOYAMA S
    Iryo; 1963 Dec; 17():736-40. PubMed ID: 14123823
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of gout attacks by phenylbutazone].
    RUIZ MORENO A
    Dia Med; 1957 Sep; 29(62):2201 passim. PubMed ID: 13473582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.